StockData
Immunocore Holdings plc logo

Immunocore Holdings plc (IMCR) stock

IMCRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/304% below fair value
$29.94−0.54 (-1.76%)

Close on Nov 13, 2026Market cap $1.54BP/E –Yield 0.00%

Immunocore statistics

85 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Feb 24, 2027 (estimated, before the open)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$1.54B
$275.32M
Enterprise Value
$640.57M
$144.91M
PS Ratio
3.59
3.66
PB Ratio
3.67
2.01
P/TBV Ratio
3.67
2.22

Enterprise valuationIndustry

EV / Sales
1.49
2.57

Share statisticsIndustry

Shares Change (YoY)
1.66%
10.8%
Shares Change (QoQ)
0.30%
0.49%
Float
44M
49M
Shares Held by Insiders
15.5%
11.6%
Shares Held by Institutions
101.8%
56.4%

Short sellingIndustry

Short Interest
8M
–
Short Interest Change
-0.10%
-0.80%
Days to Cover
14.21
5.16

Stock price statisticsIndustry

52-Week High
$40.71
–
52-Week Low
$27.50
–
20-Day Moving Average
$30.99
–
50-Day Moving Average
$31.07
–
200-Day Moving Average
$31.58
–
Average True Range (14)
$1.44
–
Price Change (1 Week)
-3.39%
-1.15%
Price Change (1 Month)
1.56%
-4.86%
Price Change (3 Months)
-14.6%
-21.1%
Price Change (6 Months)
6.74%
-20.7%
Price Change (YTD)
-13.7%
-23.6%
Price Change (1 Year)
-15.2%
-22.7%
Price Change (3 Years)
-38.9%
-29.5%
Price Change (5 Years)
-24.4%
-77.8%
Average Volume (10 Days)
550,907
–
Average Volume (20 Days)
535,712
–
Average Volume (90 Days)
471,023
–
Relative Volume
0.57
0.70
Relative Strength Index (14)
45.7
43.4
Volatility (1 Year)
37.6%
80.1%
Beta (5 Years)
0.69
1.07

MarginsIndustry

Gross Margin
98.9%
53.1%
Operating Margin
-6.76%
-38.7%
Pretax Margin
-3.98%
-11.6%
Profit Margin
-7.48%
-31.6%
EBITDA Margin
-6.76%
-27.7%
FCF Margin
-4.24%
-9.56%

Returns on capitalIndustry

Return on Equity (ROE)
-7.87%
-50.3%
Return on Assets (ROA)
-2.88%
-40.6%
Return on Capital Employed (ROCE)
-3.23%
-38.0%

Financial positionIndustry

Current Ratio
4.62
3.30
Quick Ratio
3.93
2.39
Interest Coverage
-2.37
-6.31

GrowthIndustry

Revenue Growth (YoY)
13.1%
6.82%
FCF Growth (YoY)
-717.5%
6.85%
Revenue Growth (3Y CAGR)
31.9%
2.25%

EfficiencyIndustry

Asset Turnover
0.38
0.40
Inventory Turnover
0.75
2.73
Revenue Per Employee
$819.28K
$429.29K
Profits Per Employee
-$61.30K
-$690.06K
Employee Count
524
75
WACC
8.57%
10.2%

Income statement (TTM)Industry

Revenue
$429.30M
$66.37M
Gross Profit
$424.40M
$120.78M
Operating Income
-$29.02M
-$21.40M
Pretax Income
-$17.11M
-$12.98M
Net Income
-$32.12M
-$22.39M
EBITDA
-$29.02M
-$17.04M
EPS (Diluted)
-$0.64
-$0.76

Balance sheetIndustry

Net Cash (Debt)
$901.30M
$17.80M
Net Cash Per Share
$17.50
$0.80
Equity (Book Value)
$419.71M
$53.27M
Book Value Per Share
$8.15
$1.50
Tangible Book Value
$419.71M
$26.82M
Working Capital
$830.81M
$79.93M

Cash flow (TTM)Industry

Operating Cash Flow
-$10.41M
-$12.35M
Capital Expenditures
-$7.79M
-$1.00M
Free Cash Flow
-$18.21M
-$18.21M
FCF Per Share
-$0.35
-$0.42

Dividends and yieldsIndustry

Earnings Yield
-2.08%
-22.0%
FCF Yield
-1.18%
-9.44%
Dividend Yield
0.00%
1.88%
Shareholder Yield
0.00%
0.00%
Dividend Per Share
$0.00
$0.83
Years of Dividend Growth
0
0

Taxes and interestIndustry

Interest Expense
$12.23M
$2.93M
Income Tax
$15.01M
$73.00K

Scores and fair valueIndustry

Altman Z-Score
1.45
0.23
Piotroski F-Score
3
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodIMCRS&P 500DifferenceIMCR per yearS&P 500 per year
1 month+7.6%-3.0%+10.7 pts
3 months-12.5%-2.8%−9.7 pts
Year to date-13.7%+11.5%−25.2 pts
1 year-15.4%+13.5%−28.8 pts
3 years-40.2%+77.7%−117.9 pts-15.7%+21.1%
5 years-24.4%+72.6%−97.0 pts-5.4%+11.5%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

8M IMCR shares were sold short on Oct 30, 2026, down 0.1% from the previous report. At recent volumes it would take 14.2 days to buy them back. Over the last 20 sessions, 30.0% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20267,793,995-0.1%548,59514.2
Oct 15, 20267,801,461-1.3%498,40315.7
Sep 30, 20267,903,280+1.7%381,72620.7
Sep 15, 20267,770,242-0.3%377,89320.6
Aug 31, 20267,793,032-1.3%374,59220.8
Aug 14, 20267,895,815-3.9%420,02318.8
Jul 31, 20268,217,977-8.1%472,94117.4
Jul 15, 20268,940,861-0.6%707,79912.6
Jun 30, 20268,992,351-0.5%718,64412.5
Jun 15, 20269,039,457+3.3%423,00821.4
May 29, 20268,749,260-2.5%443,95819.7
May 15, 20268,970,345+0.0%253,39935.4

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?